---
schema_version: "secwatch.filing_event.v1"
accession: "0000950103-24-015811"
form_type: "8-K"
ticker: "BHC"
cik: "0000885590"
company_name: "Bausch Health Companies Inc."
filed_at: "2024-11-01T23:59:59+00:00"
generated_at: "2026-05-30T07:10:16.329246+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Bausch + Lomb borrows $400M in new term loans maturing May 2027

## Summary
- Bausch + Lomb added $400M term loans under its credit agreement; proceeds used to repay revolver and for corporate purposes.
- Loans mature May 10, 2027, with quarterly amortization: 0.625% of principal for first 8 installments, then 1.875%.
- Interest at base rate or term SOFR plus margin: 2.25% (base) or 3.25% (SOFR); other terms unchanged.
- Bausch Health (BHC) filed the 8-K; the borrowing is at subsidiary Bausch + Lomb (BLCO).

## SEC filing metadata
- accession: 0000950103-24-015811
- form_type: 8-K
- ticker: BHC
- cik: 0000885590
- company_name: Bausch Health Companies Inc.
- filed_at: 2024-11-01T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 2.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/885590/000095010324015811/0000950103-24-015811-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/885590/000095010324015811/dp220184_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950103-24-015811
- JSON: https://secwatch.observer/filing/0000950103-24-015811.json
- Plain text: https://secwatch.observer/filing/0000950103-24-015811.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.